Cluster attacks responsive to recreational cannabis and dronabinol

Headache. 2009 Jun;49(6):914-6. doi: 10.1111/j.1526-4610.2009.01344.x. Epub 2009 Feb 11.

Abstract

Pharmacological preparations of cannabinoid compounds have a variety of therapeutic uses in medicine, including different pain syndromes, but have not been previously reported as beneficial for cluster headache. We present a patient with cluster headache who was refractory to multiple acute and preventive medications but successfully aborted his attacks with recreational marijuana use; subsequent use of dronabinol provided equally effective pain relief. The beneficial effect may be related to the high concentration of cannabinoid receptors in the hypothalamus, which has been implicated as a site of dysfunction in neuroimaging studies of patients with cluster headache.

Publication types

  • Case Reports

MeSH terms

  • Analgesics, Non-Narcotic / administration & dosage*
  • Cannabis / chemistry*
  • Cluster Headache / drug therapy*
  • Cluster Headache / metabolism
  • Cluster Headache / physiopathology
  • Dihydroergotamine / therapeutic use
  • Diphenhydramine / therapeutic use
  • Dronabinol / administration & dosage*
  • Drug Resistance / physiology
  • Drug Therapy, Combination
  • Fructose / analogs & derivatives
  • Fructose / therapeutic use
  • Humans
  • Male
  • Melatonin / therapeutic use
  • Metoclopramide / therapeutic use
  • Topiramate
  • Treatment Outcome
  • Valproic Acid / therapeutic use
  • Young Adult

Substances

  • Analgesics, Non-Narcotic
  • Topiramate
  • Fructose
  • Dihydroergotamine
  • Valproic Acid
  • Dronabinol
  • Diphenhydramine
  • Melatonin
  • Metoclopramide